CFO Treerita Essalima Johnson-Greene buys 21,000 shares at $1.23; stock down 54.8% from 52-week high and 45.1% over 90 days.
On 2026-06-15, Ocugen's Chief Financial Officer purchased 21,000 shares at $1.23, increasing her holdings from 500,000 shares to 521,000 shares. The stock has declined significantly, trading 54.8% below its 52-week high of $2.72 and down 45.1% over the past 90 days, suggesting a sharp recent sell-off. The company faces material operational headwinds: net income was $-19,177,000.00 over the most recent full fiscal year despite quarterly revenue of $1,533,000.00 and modest annual revenue growth of +8.8%. An insider equity purchase by a CFO during a steep drawdown in an unprofitable company creates a data point for investor attention regarding management's assessment of current valuation, though the motivations behind discretionary insider transactions cannot be definitively inferred from price action and fundamentals alone.